242 related articles for article (PubMed ID: 22627042)
1. The effects of aminoguanidine on retinopathy in STZ-induced diabetic rats.
Luo D; Fan Y; Xu X
Bioorg Med Chem Lett; 2012 Jul; 22(13):4386-90. PubMed ID: 22627042
[TBL] [Abstract][Full Text] [Related]
2. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
Gardiner TA; Anderson HR; Stitt AW
J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
[TBL] [Abstract][Full Text] [Related]
4. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.
Agardh E; Hultberg B; Agardh C
Curr Eye Res; 2000 Jul; 21(1):543-9. PubMed ID: 11035534
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment.
Usta MF; Bivalacqua TJ; Koksal IT; Toptas B; Surmen S; Hellstrom WJ
BJU Int; 2004 Aug; 94(3):429-32. PubMed ID: 15291881
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
Huang Y; Lin S; Zhou J
Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
[TBL] [Abstract][Full Text] [Related]
7. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
Rota R; Chiavaroli C; Garay RP; Hannaert P
Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
[TBL] [Abstract][Full Text] [Related]
8. Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies.
Lupo G; Motta C; Giurdanella G; Anfuso CD; Alberghina M; Drago F; Salomone S; Bucolo C
Biochem Pharmacol; 2013 Dec; 86(11):1603-13. PubMed ID: 24076420
[TBL] [Abstract][Full Text] [Related]
9. Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.
Roufail E; Soulis T; Boel E; Cooper ME; Rees S
Diabetologia; 1998 Dec; 41(12):1419-25. PubMed ID: 9867208
[TBL] [Abstract][Full Text] [Related]
10. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
Ottlecz A; Bensaoula T
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
[TBL] [Abstract][Full Text] [Related]
11. Elevated Nε-(carboxymethyl)lysine is associated with apoptosis of retinal pericytes in streptozotocin-induced diabetic rats.
Kim J; Kim CS; Sohn E; Kim JS
Ophthalmic Res; 2011; 46(2):92-7. PubMed ID: 21273798
[TBL] [Abstract][Full Text] [Related]
12. [An observation on early morphological changes in retinal microvascular vessels in diabetic rats].
Yang Y; He S; Liu Y
Zhonghua Yan Ke Za Zhi; 1997 May; 33(3):230-2. PubMed ID: 10437045
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S
Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551
[TBL] [Abstract][Full Text] [Related]
14. High-salt loading exacerbates increased retinal content of aquaporins AQP1 and AQP4 in rats with diabetic retinopathy.
Qin Y; Xu G; Fan J; Witt RE; Da C
Exp Eye Res; 2009 Nov; 89(5):741-7. PubMed ID: 19596320
[TBL] [Abstract][Full Text] [Related]
15. Calcium dobesilate attenuates vascular injury and the progression of diabetic retinopathy in streptozotocin-induced diabetic rats.
Padilla E; Ganado P; Sanz M; Zeini M; Ruiz E; Triviño A; Ramírez AI; Salazar JJ; Ramírez JM; Rojas B; Hoz Rd; Tejerina T
Diabetes Metab Res Rev; 2005; 21(2):132-42. PubMed ID: 15386814
[TBL] [Abstract][Full Text] [Related]
16. Tenilsetam prevents early diabetic retinopathy without correcting pericyte loss.
Hoffmann J; Alt A; Lin J; Lochnit G; Schubert U; Schleicher E; Chavakis T; Brownlee M; Van der Woude FJ; Preissner KT; Hammes HP
Thromb Haemost; 2006 Apr; 95(4):689-95. PubMed ID: 16601840
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
18. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
19. A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats.
Bhatwadekar A; Glenn JV; Figarola JL; Scott S; Gardiner TA; Rahbar S; Stitt AW
Br J Ophthalmol; 2008 Apr; 92(4):545-7. PubMed ID: 18211931
[TBL] [Abstract][Full Text] [Related]
20. Exogenous advanced glycosylation end products induce diabetes-like vascular dysfunction in normal rats: a factor in diabetic retinopathy.
Xu X; Li Z; Luo D; Huang Y; Zhu J; Wang X; Hu H; Patrick CP
Graefes Arch Clin Exp Ophthalmol; 2003 Jan; 241(1):56-62. PubMed ID: 12545293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
